Cardiology News
Practice Points on Heart Failure
Heart failure (HF) is a common (1-3%) clinical issue that continues to cause significant hospitalisation and mortality in NZ. Presentation is varied and the diagnosis is based on multiple clinical features. History is important. Symptoms are caused by decreased cardiac output (fatigue, dyspnoea) or congestion from increased cardiac filling pressures (orthopneoa, paroxysmal nocturnal dyspnoea and oedema). Clinical ...
Practice Points on Familial Hypercholesterolemia
Familial Hypercholesterolemia (FH) is a critical health concern, particularly for its stealthy yet profound impact on cardiovascular disease. As frontline healthcare providers, General Practitioners in New Zealand play a pivotal role in its early detection and management. Here are some Practice Points on FH, outlining its prevalence, impact, and current treatment options, including recent advancements in ...
Practice Points on Atrial Fibrillation (AF) management
We are pleased to share some important practice points on Atrial Fibrillation (AF) management that can guide your clinical practice. These insights are drawn from recent research and clinical practice, providing further insight into the care of patients with AF: 1. Prioritise Rhythm Control for AF under 75: For patients under the age of ...
Practice Points on CT coronary angiography (CTCA)
We are pleased to share some important practice points on investigation for chest pain syndromes with CT coronary angiography (CTCA). These points are drawn from clinical experience using CTCA since 2007 and research and guideline updates that have established CTCA as a first-line investigation for chest pain syndromes. CTCA has evolved to become an accepted ...
Heart Failure with preserved Ejection Fraction (HFpEF)- diagnosis and potential treatments options
The recorded sessions from the annual GP symposium, including sessions on heart failure, are available online to view. At the most recent symposium I reviewed treatment of heart failure. In this newsletter we focus on HFpEF. It is now often stated that of the new diagnosis of heart failure, half are those with preserved left ...
25 Years of Heart Care: A Video Journey
Take a moment to view our special video series celebrating 25 years of heart care at Ascot Cardiology Group. Join Veteran Broadcaster Leighton Smith as he sits down with our founder, Dr. Warwick Jaffe, to explore the evolution of cardiology over the past quarter-century. Through these interviews, Dr. Jaffe shares his insights on the advancements ...
Watch the videos from the Ascot Cardiology Symposium 2024.
We were thrilled to have such a strong turnout for this year’s Cardiology Symposium. Thank you to all of the GPs who attended and also to our industry partners who came along and showcased some of their innovative technologies. All of the talks were videoed and can be viewed on the event website by clicking here. ...
Electrophysiology at Ascot Cardiology Group
Click here for Patient information on the Electrophysiology Study (EPS) offered at Ascot Cardiology Group. Transcript: Dr Patricia Ding: Morning everyone, I’m Patricia Ding, Cardiologist. I’m here with Dr. Warwick Jaffe, Interventional Cardiologists from Ascot Cardiology. So Warwick, I hear that we’ve got some new electrophysiology services available at Ascot Angiography. Can you tell ...
Dilated Cardiomyopathy: Taking medications after heart function returns to normal range
Transcript: Dr Patricia Ding: Good morning, Warwick. Dr Warwick Jaffe: Good morning, Patricia. Dr Patricia Ding: Hi there. I’m Patricia Ding, Cardiologist. I’m here with the experienced Interventional Cardiologist, Dr. Warwick Jaffe from Ascot Cardiology. So now, as a clinician, we always face this challenge about how to convince our patients to take medications. I ...
Dr Patrick Gladding on EPA (fish oil) and Triglycerides
Transcript: Dr Patricia Ding: I’m Patricia Ding, Cardiologist. I’m here today with Dr. Patrick Gladding. Hi Patrick. Dr Patrick Gladding: Hi, everyone. Hi, Patricia. Dr Patricia Ding: Okay, right. So can you tell us about the topic today? Dr Patrick Gladding: So I’m just going to talk to you about triglycerides. It’s an area that’s ...
The Ischemia Trial
Transcript: Dr Patricia Ding: I’m Patricia Ding, Cardiologist, and I’m here with Dr. Tim Glenie, Interventional Cardiologist. Hi, Tim. Dr Tim Glenie: Hi, Patricia. How are you? Dr Patricia Ding: Right, so you’re going to tell us about The Ischemia Trial. What is this trial about? Dr Tim Glenie: The Ischemia Trial was published earlier ...
Management of atrial fibrillation in primary care setting, the ALL-IN trial
Transcript: Dr Warwick Jaffe: Patricia, can you tell me what the trial was about? Dr Patricia Ding: Right, so this is a trial called ALL-In Trial conducted in Netherlands, involving 26 GP practices. They cluster randomised them to the integrated care group versus the usual care group. There were about 1,200 patients with 500 also ...
Dr Warwick Jaffe on current lipid management
Transcript: Dr Patricia Ding: Right. Good morning. My name is Patricia Ding. I’m one of the cardiologists at Ascot Cardiology. I’m here with Dr. Warwick Jaffe, Interventional Cardiologist from Ascot Cardiology. Morning, Warwick. Dr Warwick Jaffe: Morning, Patricia. Dr Patricia Ding: So, and tell us about the current state of play for lipid management. Dr ...
ECG Treadmill, training and support provided to TTM Hospital, Samoa
Ascot Cardiology Group Interventional Cardiologist Dr Warwick Jaffe and Nurse Mela Yudilevich travelled to Apia, Samoa this January as part of their ongoing commitment to train and support local medical staff in cardiac care. Dr Jaffe and the Ascot Cardiology Group team have continued to work closely with the Samoan Government over many years, visiting ...
Oral anticoagulation with Antiplatelet Therapy
An Update on Oral anticoagulation with Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Interventions The challenge of managing atrial fibrillation in patients who have undergone percutaneous coronary intervention for the treatment of coronary disease, is one widely shared and fraught throughout the medical field. Given the emergence of noval oral anticoagulants (NOAC) and updated current ...
Restoring the Rhythm . . . Atrial fibrillation under the scope
The global burden of atrial fibrillation remains unknown, but in New Zealand it is estimated that AF affects a minimum of five percent of the population. Atrial fibrillation is touted as the most common cardiac arrhythmia and complications can be severe – increased risk of stroke, heart failure, myocardial infarction and dementia. Management of atrial ...
Heart Failure Therapies in Focus . . . Cardiac Resynchronisation
Worldwide cardiologists and doctors alike are vested in therapies to combat heart failure and explore measures to improve the quality of life for patients – new implanted device based therapies are under active investigations- including devices that can modulate cardiac contractility, and multiple other modes to alter vagal tone. In an ever-evolving landscape of treatment ...
Heart Failure Complexities . . . A ‘black box’ of treatment measures
Around the globe, in developed countries, 1-2% of the adult population have heart failure, rising to over ten percent in those aged over 70 years. Heart failure occurs not just with reduced left ventricular ejection fraction, but also with preserved ejection fraction.– with figures steadily climbing year-on-year. However, despite the prevalence of modern-day interventions – ...
Cardiovascular Movements and Measures . . . Looking back, moving forward
Therapy treatments for cardiovascular conditions have varied in significance over the past 100 years. Post mid-1950s, experimentation in the field has seen both age-old and progressive therapy treatments come to the fore. Here Dr Tim Glenie reveals trials and tribulations behind two cardiovascular treatments that have created decades of waves across the medical world. Harking ...
Treating Hypertension Beyond Genomics . . . Personalised care and technology in focus
Treating the world’s largest ‘silent killer’ extends well beyond drug intervention, guidelines and textbook literature. Here Ascot Cardiology Group Cardiologist Dr Patrick Gladding provides insight into technological advances in blood pressure monitoring and ECG sensitivities, and the key role personalisation plays in effectively treating patients with hypertension. “Personalised medicine is more than genomics, it’s also wireless ...
GP Practice Points
Sign up for our GP Practice Points and keep up to date with the
latest news, case studies and Symposium information.
Ascot Hospital, Level 3
90 Greenlane East
Remuera, Auckland 1051
PO Box 17264,
Greenlane, Auckland 1546